Cong Chen
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Ferroptosis and cancer prognosis
Papers in
-
- Breast Cancer Treatment Studies 3
-
- Sirtuins and Resveratrol in Medicine 3
- Co-authors
- Linbo Wang (15 shared papers)Jichun Zhou (13 shared papers)Yongxia Chen (11 shared papers)Zhaoqing Li (10 shared papers)Lini Chen (6 shared papers)Misha Mao (8 shared papers)Jingjing Yang (5 shared papers)Xun Zhang (6 shared papers)
- Journals
- Biomarker Research (3 papers)Frontiers in Oncology (2 papers)Oncotarget (2 papers)Fuel (2 papers)Journal of Hazardous Materials (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Cong Chen
56 papers receiving 2k citations
Cong Chen's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 274
- Pulmonary and Respiratory Medicine 457
- Drug Discovery 3
- Geriatrics and Gerontology 35
- Oncology 209
Countries citing papers authored by Cong Chen
This map shows the geographic impact of Cong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Chen more than expected).
Fields of papers citing papers by Cong Chen
This network shows the impact of papers produced by Cong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Chen. The network helps show where Cong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer Hit paper breakdown → | 2021 | 310 |
| 2 | Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities Hit paper breakdown → | 2022 | 216 |
| 3 | 2017 | 170 | |
| 4 | 2020 | 161 | |
| 5 | 2022 | 146 | |
| 6 | 2019 | 82 | |
| 7 | 2014 | 67 | |
| 8 | 2019 | 63 | |
| 9 | 2012 | 61 | |
| 10 | 2014 | 55 | |
| 11 | 2022 | 53 | |
| 12 | 2014 | 48 | |
| 13 | 2022 | 43 | |
| 14 | 2019 | 33 | |
| 15 | 2021 | 30 | |
| 16 | 2017 | 27 | |
| 17 | 2018 | 26 | |
| 18 | 2022 | 26 | |
| 19 | 2022 | 26 | |
| 20 | 2017 | 25 |
About Cong Chen
Cong Chen is a scholar working on Cancer Research, Geriatrics and Gerontology, Biomaterials, Pulmonary and Respiratory Medicine and Pharmaceutical Science, having authored 56 papers that have together received 2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Epilepsy research and treatment (4 papers), Aortic aneurysm repair treatments (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Breast Cancer Treatment Studies (3 papers) and Coal Combustion and Slurry Processing (2 papers). The work is most often cited by research in Cancer Research (274 citations), Pulmonary and Respiratory Medicine (457 citations), Drug Discovery (3 citations), Geriatrics and Gerontology (35 citations) and Oncology (209 citations). Cong Chen has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Linbo Wang, Jichun Zhou, Yongxia Chen, Zhaoqing Li, Lini Chen, Misha Mao, Jingjing Yang, Xun Zhang, Yulu Zhou and Wenying Zhuo. Their work appears in journals such as Biomarker Research, Frontiers in Oncology, Oncotarget, Fuel and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.